Adele M. Gulfo

update update

INVESTOR CENTER

Bemis creates exceptional packaging for food, consumer product, healthcare, and industrial applications.

Our strategic objectives are to accelerate growth, focus innovation, and continuously improve, all aimed at delivering strong financial performance. In 2017, we launched “Agility” – our actions to fix, strengthen, and grow our business.

Our Vision is: passionate commitment to the growth and success of our customers will make Bemis the clear choice for inspired packaging solutions.

STOCK INFORMATION

NYSE: BMS

(Common Stock)

Loading
Loading
Loading
Loading

3 Image Hover Swap - Economic, Environmental, Social

Adele M. Gulfo

Chief of Commercial Development, Roivant Sciences, Inc.

Adele M. Gulfo serves as Chief of Commercial Development for Roivant Services, Inc. since May 2018. She previously served as EVP & Head of Global Commercial Development and Chief Strategy Officer of Mylan N.V. (NASDAQ: MYL), a leading global pharmaceutical company, from 2014 until her retirement in January 2018. Prior to joining Mylan, Ms. Gulfo spent a total of 14 years at Pfizer, Inc. and legacy companies, most recently as President, Latin America, before that as President and General Manager, U.S. Primary Care, and earlier where she launched LIPITOR in 1997 to become the world's best-selling medicine. Previously, Ms. Gulfo held leadership positions at AstraZeneca Pharmaceuticals, SpectraTech Inc., and Fischer Scientific. She holds eight patents.

Ms. Gulfo's experience in the healthcare industry brings valuable marketing, operational and strategic insight to the Board. She has also held various leadership roles with global public companies, giving her valuable strategic experience and perspective in understanding global challenges and opportunities. 

Director since 2015

Bemis Board Committee:
Audit Committee